“…Numerous clinical trials have examined the integration of Androgen Deprivation Therapy (ADT) with External Beam Radiotherapy (EBRT) and have investigated the optimal strategies for ADT duration and sequencing in this combined treatment approach [1] . These trials have shown that the addition of ADT to EBRT improves cancer specific survival (CSS), biochemical control and overall survival (OS), and this is also true in the era of dose escalation in EBRT [2] .…”